Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · IEX Real-Time Price · USD
14.90
+0.35 (2.41%)
At close: Mar 28, 2024, 4:00 PM
15.20
+0.30 (2.01%)
After-hours: Mar 28, 2024, 7:16 PM EDT

Pliant Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
1.589.697.5741.8257.050
Revenue Growth (YoY)
-83.69%27.91%-81.89%-26.70%--
Gross Profit
1.589.697.5741.8257.050
Selling, General & Admin
57.9339.9527.5617.2710.936.5
Research & Development
127.896.9477.5566.1947.3524.42
Operating Expenses
185.73136.89105.1183.4658.2830.92
Operating Income
-184.15-127.2-97.54-41.65-1.23-30.92
Interest Expense / Income
1.270.790000
Other Expense / Income
-24.08-4.67-0.27-0.11-0.6-0.64
Pretax Income
-161.34-123.32-97.26-41.53-0.63-30.28
Net Income
-161.34-123.32-97.26-41.53-0.63-30.28
Preferred Dividends
00006.234.88
Net Income Common
-161.34-123.32-97.26-41.53-6.86-35.15
Shares Outstanding (Basic)
5942362121
Shares Outstanding (Diluted)
5942362121
Shares Change
39.75%17.21%67.94%1214.82%39.29%-
EPS (Basic)
-2.75-2.94-2.71-1.95-4.22-30.16
EPS (Diluted)
-2.75-2.94-2.71-1.95-4.22-30.16
Free Cash Flow
-117.28-96.39-77.4-38.8-3.71-30.65
Free Cash Flow Per Share
-2.00-2.29-2.16-1.82-2.29-26.30
Gross Margin
100.00%100.00%100.00%100.00%100.00%-
Operating Margin
-11654.75%-1313.37%-1288.10%-99.59%-2.16%-
Profit Margin
-10211.14%-1273.32%-1284.51%-99.32%-12.02%-
Free Cash Flow Margin
-7422.91%-995.26%-1022.13%-92.79%-6.51%-
EBITDA
-155.84-118.85-94.06-40.220.48-29.61
EBITDA Margin
-9863.16%-1227.15%-1242.19%-96.19%0.84%-
Depreciation & Amortization
4.233.683.21.311.110.67
EBIT
-160.07-122.53-97.26-41.53-0.63-30.28
EBIT Margin
-10130.95%-1265.15%-1284.51%-99.32%-1.11%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).